Median Arcuate Ligament Syndrome

Comprehensive Clinical Guide: Median Arcuate Ligament Syndrome (MALS)

1. Introduction and Clinical Overview

Median Arcuate Ligament Syndrome (MALS), also historically referred to as Celiac Artery Compression Syndrome or Dunbar Syndrome, is a rare and often controversial clinical entity characterized by the extrinsic compression of the celiac artery (CA) by the median arcuate ligament (MAL) of the diaphragm.

While anatomical compression of the celiac artery is a relatively common incidental finding in asymptomatic patients—occurring in approximately 10% to 24% of the population—the symptomatic presentation is significantly rarer. Clinically, MALS manifests as a triad of chronic postprandial abdominal pain, weight loss, and occasionally, an abdominal bruit. Because the symptoms are non-specific and often mimic more common gastrointestinal disorders, MALS remains a diagnosis of exclusion, requiring a high index of clinical suspicion and a multidisciplinary diagnostic approach.

2. Etiology and Pathophysiology

The median arcuate ligament is a fibrous arch that connects the crura of the diaphragm on either side of the aortic hiatus. In MALS, the ligament is positioned lower than normal, crossing the celiac artery rather than the aorta, resulting in compression.

The Dual-Mechanism Hypothesis

The pathophysiology of MALS is believed to be multifactorial, involving both ischemic and neurogenic components:

1. Vascular/Ischemic Component: The compression of the celiac artery leads to stenosis, which may cause hypoperfusion of the foregut organs (stomach, liver, spleen, and pancreas). While the collateral circulation via the pancreaticoduodenal arcades (connecting the celiac and superior mesenteric arteries) usually compensates, postprandial demand can exceed supply, leading to "abdominal angina."
2. Neurogenic Component: The celiac ganglion, a dense plexus of nerves situated near the celiac artery, is often chronically compressed or irritated by the low-lying ligament. This autonomic dysfunction is thought to contribute significantly to the pain profile, explaining why some patients experience relief after neurolysis (ganglionectomy) even if the vascular stenosis is not fully resolved.

3. Clinical Presentation and Staging

Patients typically present in the 3rd to 5th decade of life, with a higher prevalence in females (often with a lean body habitus).

Standard Clinical Features

• Postprandial Pain: Described as dull, aching, or cramping, beginning 15–30 minutes after eating.
• Weight Loss: Often significant, driven by "sitophobia" (fear of eating) to avoid pain.
• Physical Exam: A systolic epigastric bruit is often present, which may change in intensity with respiration (becoming louder during expiration when the diaphragm moves superiorly).

Clinical "Staging" (Modified Approach)

While no formal universal staging system exists, clinicians often utilize the following categorization for surgical decision-making:

• Type I (Asymptomatic): Anatomical compression on imaging without clinical symptoms. No intervention required.
• Type II (Symptomatic - Early): Classic postprandial pain and weight loss. Evidence of CA stenosis on imaging.
• Type III (Advanced/Chronic): Significant weight loss, evidence of collateralization, and potential psychological impact due to chronic pain.

4. Differential Diagnosis

Because abdominal pain is a universal symptom, MALS must be differentiated from:
* Gastrointestinal: Gastroparesis, peptic ulcer disease, chronic pancreatitis, gallbladder disease.
* Vascular: Superior Mesenteric Artery (SMA) syndrome, chronic mesenteric ischemia (atherosclerotic).
* Functional: Irritable Bowel Syndrome (IBS), functional dyspepsia.
* Neurological: Referred spinal pain or radiculopathy.

5. Key Diagnostic Tests

The diagnostic pathway for MALS is strictly hierarchical:

1. Duplex Ultrasound (DUS): The first-line screening tool. It allows for the measurement of peak systolic velocity (PSV) in the celiac artery. A PSV > 200 cm/s is highly suggestive of significant stenosis.
2. CT Angiography (CTA): The gold standard for anatomical visualization. It demonstrates the "hooked" appearance of the celiac artery and the precise relationship with the MAL.
3. Magnetic Resonance Angiography (MRA): A non-ionizing alternative for patients with renal impairment or those needing to avoid contrast dye.
4. Celiac Plexus Block: A diagnostic procedure where local anesthetic is injected into the celiac ganglion. If the patient experiences temporary relief of pain, it confirms the neurogenic component of the syndrome and is a positive prognostic indicator for surgical success.

6. Risks, Side Effects, and Contraindications

Surgical intervention (laparoscopic or robotic-assisted MAL release) carries specific risks:

• Vascular Injury: The celiac artery or its branches (left gastric, splenic, hepatic) are at risk of injury during the dissection of the fibrous tissue.
• Intra-operative Bleeding: The area is dense with collateral vessels; uncontrolled hemorrhage is a rare but catastrophic complication.
• Incomplete Release: Failure to fully release all ligamentous fibers may lead to symptom recurrence.
• Contraindications: Surgery is generally contraindicated in patients where the abdominal pain is clearly attributable to other comorbidities (e.g., active malignancy, severe psychiatric disorders) or in asymptomatic patients (Type I).

7. Long-Term Prognosis

The prognosis following successful surgical release of the MAL is generally favorable for properly selected patients.
* Success Rates: 70%–85% of patients report significant or total resolution of symptoms.
* Factors for Success: Younger age, shorter duration of symptoms, and a positive response to a diagnostic celiac plexus block are the strongest predictors of a positive outcome.
* Post-Op Monitoring: Patients should be monitored for weight gain and the cessation of sitophobia. In cases of persistent symptoms, further vascular evaluation (e.g., stenting) may be considered, though this is rarely required if the initial decompression is adequate.

8. Massive FAQ Section

1. Is MALS a life-threatening condition?
Rarely. MALS is typically a chronic, debilitating condition that affects quality of life rather than presenting as an acute emergency. However, severe weight loss can lead to secondary complications.

2. Why is MALS considered a "diagnosis of exclusion"?
Because anatomical compression is common in healthy people, doctors must rule out more common causes of abdominal pain (like ulcers or gallbladder issues) before attributing symptoms to MALS.

3. Does everyone with a compressed celiac artery need surgery?
Absolutely not. If there are no symptoms, no intervention is required. Surgery is reserved for those with clear, documented clinical symptoms.

4. What is the role of the celiac plexus block?
It acts as a "test drive." If the pain stops after the block, it proves the celiac ganglion is involved in the pain cycle, suggesting surgery will likely be successful.

5. How is the surgery performed?
It is usually performed laparoscopically or via robotic assistance. The surgeon divides the median arcuate ligament and performs a neurolysis (removing the nerve fibers of the celiac ganglion).

6. Can MALS cause long-term digestive damage?
Prolonged ischemia can theoretically lead to atrophy of the foregut, but this is rare. Most complications arise from malnutrition due to long-term avoidance of food.

7. Is there a non-surgical treatment for MALS?
Conservative management focuses on pain management, nutritional support, and potentially avoiding activities that worsen compression. However, surgery is the only definitive treatment for the anatomical obstruction.

8. Will I need a stent after the ligament is released?
Usually, no. Once the ligament is released, blood flow typically normalizes. Stenting is only reserved for cases where the celiac artery has suffered permanent structural damage (intimal hyperplasia) from chronic compression.

9. What is the recovery time for MALS surgery?
Most patients stay in the hospital for 2–4 days and return to light activity within 2–3 weeks. Full recovery depends on the patient's nutritional status pre-surgery.

10. Can MALS recur after surgery?
Recurrence is possible if scar tissue (fibrosis) forms around the celiac artery after the surgery, re-compressing the vessel. However, modern surgical techniques have significantly reduced this risk.

9. Conclusion

Median Arcuate Ligament Syndrome is a complex, high-stakes diagnosis that sits at the intersection of vascular surgery, gastroenterology, and pain management. While the anatomical finding of a low-lying ligament is common, the clinical syndrome requires a rigorous diagnostic pathway to ensure that surgical intervention is both warranted and likely to succeed. With proper patient selection and a combined approach of ligament release and neurolysis, the majority of patients can return to a normal, pain-free lifestyle.